These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 40264)

  • 1. The preclinical testing of drugs for opiate-like dependence-producing properties.
    Hill RC; Roemer D; Buescher HH
    Pharmacol Ther B; 1979; 5(1-3):505-9. PubMed ID: 40264
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of primates in screening dependence liability.
    Swain HH
    Pharmacol Ther B; 1979; 5(1-3):519-22. PubMed ID: 115019
    [No Abstract]   [Full Text] [Related]  

  • 3. Dependence studies on new compounds in the rhesus monkey, rat and mouse (1989).
    Aceto MD; Bowman ER; Harris LS; May EL
    NIDA Res Monogr; 1989; 95():578-631. PubMed ID: 2641054
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug dependence potential of 1-(m-methoxyphenyl)-2-dimethylaminomethyl)-cyclohexan-1-ol hydrochloride (tramadol) tested in monkeys.
    Yanagita T
    Arzneimittelforschung; 1978; 28(1a):158-63. PubMed ID: 415747
    [No Abstract]   [Full Text] [Related]  

  • 5. Riluzole decreases the abstinence syndrome and physical dependence in morphine-dependent mice.
    Sepúlveda J; Astorga JG; Contreras E
    Eur J Pharmacol; 1999 Aug; 379(1):59-62. PubMed ID: 10499372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of propranolol on antinociceptive, tolerance- and dependence-producing properties of morphine in rodents and monkeys.
    Cowan A; Macfarlane IR
    Eur J Pharmacol; 1975 Nov; 34(1):87-94. PubMed ID: 11999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dependence potential of drotebanol, codeine and thebaine tested in rhesus monkeys.
    Yanagita T; Miyasato K; Oinuma N; Yiyohara H
    Bull Narc; 1977; 29(1):33-46. PubMed ID: 405065
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis and analgetic activity of 1,2,3,4,5,6-hexahydro-1,6-methano-3-benzozocines.
    Mazzocchi PH; Harrison AM
    J Med Chem; 1978 Feb; 21(2):238-40. PubMed ID: 413922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinical trial to determine if corelease of morphine and naltrexone from crushed extended-release capsules induces withdrawal in opioid-dependent patients: a descriptive analysis of six patients.
    Setnik B; Roland CL; Goli V; Sommerville K; Webster L
    J Opioid Manag; 2013; 9(2):139-50. PubMed ID: 23709323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Termination of a schedule complex associated with intravenous injections of nalorphine in morphine-dependent rhesus monkeys.
    Tang AH; Morse WH
    Pharmacol Rev; 1975 Sep; 27(3):407-17. PubMed ID: 817311
    [No Abstract]   [Full Text] [Related]  

  • 11. [Development of a opioid dependence in a not diagnosed restless legs syndrome].
    Hain C
    Psychiatr Prax; 2002 Sep; 29(6):322-3. PubMed ID: 12402965
    [No Abstract]   [Full Text] [Related]  

  • 12. [The withdrawal syndrome and lipid peroxidation during the chronic administration of narcotic analgesics to rats].
    Konstantinopol'skiĭ MA; Pirozhkov SV; Solov'eva AG; Panchenko LF; Barkov NK
    Eksp Klin Farmakol; 1992; 55(1):21-4. PubMed ID: 1363943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some morphine-like properties of a potent antinociceptive synthetic pentapeptide in relation to physical dependence in rodents [proceedings].
    Baxter MG; Follenfant RL; Miller AA; Sethna DM
    Br J Pharmacol; 1977 Mar; 59(3):523P. PubMed ID: 557357
    [No Abstract]   [Full Text] [Related]  

  • 14. [Opioid analgesics in the treatment of non-malignant chronic pain].
    Eriksen J; Clausen TG; Borgbjerg FM
    Ugeskr Laeger; 1994 Jan; 156(5):621-3, 626-7. PubMed ID: 7910424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of ritanserin on the formation and expression of an opiate abstinence syndrome].
    Verbitskaia EV; Kudriashova MF
    Eksp Klin Farmakol; 1997; 60(1):19-21. PubMed ID: 9162274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some methodological problems in assessing dependence-producing properties of drugs in animals.
    Yanagita T
    Pharmacol Rev; 1975 Dec; 27(4):503-9. PubMed ID: 4823
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of opioid agonists in maintaining responding and in suppressing morphine withdrawal in rhesus monkeys.
    Young AM; Swain HH; Woods JH
    Psychopharmacology (Berl); 1981; 74(4):329-35. PubMed ID: 6794076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral activation induced by D(2)-like receptor stimulation during opiate withdrawal.
    Druhan JP; Walters CL; Aston-Jones G
    J Pharmacol Exp Ther; 2000 Aug; 294(2):531-8. PubMed ID: 10900229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STUDYING THE PHYSICAL DEPENDENCE ON AND TOLERANCE TO THE ANTINOCICEPTIVE EFFECT OF RU-1205 SUBSTANCE.
    Grechko OY; Shtareva DM; Spasov AA; Litvinov LA; Rashchenko AI
    Eksp Klin Farmakol; 2016 Aug; 79(4):8-11. PubMed ID: 29949697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analgesic activity and pharmacological characterization of N-[1-phenylpyrazol-3-yl]-N-[1-(2-phenethyl)-4-piperidyl] propenamide, a new opioid agonist acting peripherally.
    Goicoechea C; Sánchez E; Cano C; Jagerovic N; Martín MI
    Eur J Pharmacol; 2008 Oct; 595(1-3):22-9. PubMed ID: 18706410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.